IP Library Granted Patent US 7,662,410
Granted Patent B2
US 7,662,410 · App. 11/439,466 · Granted Feb 16, 2010

Membrane scaffold proteins and embedded membrane proteins

Assignee: The Board of Trustees of the University of Illinois
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,662,410
App. No.
11/439,466
Granted
Feb 16, 2010
Kind
B2
Abstract

Membrane proteins are difficult to express in recombinant form, purify, and characterize, at least in part due to their hydrophobic or partially hydrophobic properties. Membrane scaffold proteins (MSP) assemble with target membrane or other hydrophobic or partially hydrophobic proteins or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; they are improved over liposomes and detergent micelles. In the presence of phospholipid, MSPs form nanoscopic phospholipid bilayer disks, with the MSP stabilizing the particle at the perimeter of the bilayer domain. The particle bilayer structure allows manipulation of incorporated proteins in solution or on solid supports, including for use with such surface-sensitive techniques as scanning probe microscopy or surface plasmon resonance. The nanoscale particles facilitate pharmaceutical and biological research, structure/function correlation, structure determination, bioseparation, and drug discovery.

Claims (5)

1. A nanoscale particle comprising an artificial membrane scaffold protein and at least one embedded membrane protein, and further comprising a phospholipid or a mixture of phospholipids, wherein said nanoscale particle has a diameter between 5 nm and 500 nm, wherein said artificial membrane scaffold protein, in an aqueous environment, self-assembles in the presence of a phospholipid or in the presence of a mixture of phospholipids, into a nanoscale particle between about 5 nm and about 500 nm in diameter, wherein said membrane scaffold protein is amphipathic and wherein said membrane scaffold protein comprises an amino acid sequence selected from the group consisting of SEQ ID NO:6, SEQ ID NO:9, SEQ ID NO:17, amino acids 13 to 414 of SEQ ID NO:17, SEQ ID NO:19, amino acids 13 to 422 of SEQ ID NO:19, SEQ ID NO:23, amino acids 13 to 168 of SEQ ID NO:23, SEQ ID NO:29, amino acids 13 to 169 of SEQ ID NO:29, SEQ ID NO:43, amino acids 13 to 201 of SEQ ID NO:43, SEQ ID NO:44, amino acids 13 to 201 of SEQ ID NO:44, SEQ ID NO:45, and amino acids 13 to 392 of SEQ ID NO:45.

2. The nanoscale particle of claim 1 , wherein said embedded membrane protein is a cytochrome P450 protein.

3. The nanoscale particle of claim 2 , wherein the cytochrome P450 protein is a human liver microsomal cytochrome P450.

4. The nanoscale particle of claim 2 , wherein the cytochrome P450 protein is a rabbit cytochrome P450 2B4 protein.

5. The nanoscale particle of claim 2 , wherein the cytochrome P450 protein is an insect microsomal cytochrome P450 6B1 protein.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 8, 2010
From: UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024492/0418 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2007
From: SLIGAR, STEPHEN G.; BAYBURT, TIMOTHY H.
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 019182/0124 →
Continuity (3)
Division 0999008700 · Nov 20, 2001
Provisional Application 6025223300 · Nov 20, 2000
Related Publication 20060211093A1 · Sep 21, 2006